Selecting patients for osteoporosis therapy

Current Osteoporosis Reports

Volumn 4, Issue 3, 2006, Pages 91-95

  Silverman, Stuart L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

BONE DENSITY; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PATIENT IDENTIFICATION; REVIEW; RISK FACTOR; WORLD HEALTH ORGANIZATION;

AGE FACTORS; BONE DENSITY; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; PATIENT SELECTION; WORLD HEALTH ORGANIZATION;

EID: 33750311940     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-996-0027-0     Document Type: Review

References (47)

1. Kanis JA, Dawson A, Oden A, et al.: Cost-effectiveness of preventing hip fracture in the general female population. Osteoporos Int 2001, 12:356-361.
2. Kanis JA, Melton LJ 3rd, Christiansen C, et al.: The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
3. Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254-1259.
4. Siris ES, Chen YT, Abbott TA, et al.: Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004, 164:1108-1112.
5. Wainwright SA, Marshall LM, Ensrud KE, et al.; Study of Osteoporotic Fractures Research Group: Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005, 90:2787-2793.
6. van der Klift M, de Laet CE, McCloskey EV, et al.: Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 2004, 19:1172-1180.
7. Sornay-Rendu E, Munoz F, Garnero P, et al.: Identification of osteopenic women at high risk of fracture: the OFELY Study. J Bone Miner Res 2005, 20:1813-1819.
8. Kanis JA, Johnell O: Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 2005, 16:229-238.
9. Kanis JA, Johnell O, Oden A, et al.: Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001, 12:989-995.
10. Ettinger B, Black DM, Mitlak BH, et al. for the Multiple Outcomes of Raloxifene (MORE) Investigators: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999, 282:637-645.
11. Black DM, Thompson DE, Bauer DC, et al.: Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab 2000, 85:4118-4124.
12. Cummings SR, Black DM, Thompson DE, et al.: Effects of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998, 280:2077-2082.
13. Jones G, Nguyen TV, Sambrook PN, et al.: Symptomatic fracture incidence in elderly men and women. The Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 1994, 4:277-282.
14. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN: Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996, 144:255-263.
15. Fujiwara S, Kasagi F, Yamada M, Kodama K: Risk factors for hip fracture in Japanese cohort. J Bone Miner Res 1997, 12:998-1004.
16. Fujiwara S, Fumiyoshi K, Masunari N, et al.: Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 2003, 18:1547-1553.
17. O'Neill TW, Felsenberg D, Varlow J, et al.: The prevalence of vertebral deformity in European men and women: European vertebral osteoporosis study. J Bone Miner Res 1996, 11:1010-1017.
18. Felsenberg D, Silman AJ, Lunt M, et al.: Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002, 17:716-724.
19. Ismail AA, Pye SR, Cockerill WC, et al.: Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 2002, 13:565-571.
20. Rollins JA, Schott AM, Garnero P, et al.: Risk factors for hip fracture in women with high BMD: the EPIDOS study. Osteopor Int 2005, 16:149-154.
21. Svanborg A: Seventy-year-old people in Gothenburg. A population study in an industrialized Swedish city. II. General presentation of social and medical conditions. Acta Med Scand Suppl 1977, 611:5-37.
22. Johansson C, Black D, Johnell O, et al.: Bone mineral density is a predictor of survival. Calcif Tissue Int 1998, 63:190-196.
23. Stenstrom M, Olsson JO, Mellstrom D: Thyroid hormone replacement is not related to increased risk of osteoporosis. Osteoporos Int 2000, 11(suppl 2):S144.
24. Johansson H, Oden A, Johnell O, et al.: Optimization of BMD measurements to identify high risk groups for treatment-a test analysts. J Bone Miner Res 2004, 19:906-913.
25. Honkanen R, Kroger H, Tuppurainen M, et al.: Fractures and low axial bone density in perimenopausal women. J Clin Epidemiol 1995, 48:881-888.
26. Albrand G, Munoz F, Sornay-Rendu E, et al.: Independent predictors of all osteoporosis-related fractures in healthy post-menopausal women: the OFELY study. Bone 2003, 32:78-85.
27. Sawka AM, Thabane L, Papaioannou A, et al.; CaMos Investigators: Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2005, 16:1836-1840.
28. Melton LJ 3rd, Crowson CS, O'Fallon WM, et al.: Relative contributions of bone density, bone turnover and clinical risk factors to long-term fracture prediction. J Bone Miner Res 2003, 18:312-318.
29. Melton LJ 3rd, Atkinson EJ, O'Connor MK, et al.: Bone density and fracture risk in men. J Bone Miner Res 1998, 13:1915-1923.
30. Kanis JA, Johnell O, De Laet C, et al.: A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004, 35:375-382. This paper shows the importance of a history of previous fracture as a risk factor for fracture independent of BMD.
31. Johnell O, Kanis JA, Oden A, et al.: Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005, 20:1185-1194.
32. De Laet C, Kanis JA, Oden A, et al.: Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005, 16:1330-1338.
33. Kanis JA, Johansson H, Oden A, et al.: A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004, 19:893-899. This paper shows the importance of prior corticosteroid use as a risk factor for fracture independent of BMD.
34. Kanis JA, Johansson H, Oden A, et al.: A family history of fracture and fracture risk: a meta-analysis. Bone 2004, 35:1029-1037. This paper shows the importance of family history of fracture as a risk factor for fracture independent of BMD.
35. Kanis JA, Johnell O, Oden A, et al.: Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005, 16:155-162. This paper shows smoking as a risk factor for fracture independent of BMD.
36. Kanis JA, Johansson H, Johnell O, et al.: Alcohol intake as a risk factor for fracture. Osteoporos Int 2005, 16:737-742. This paper shows alcohol intake as a risk factor for fracture independent of BMD.
37. Kanis JA, Borgstrom F, De Laet C, et al.: Assessment of fracture risk. Osteoporos Int 2005, 16:581-589.
38. De Laet C, Oden A, Johansson H, et al.: The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 2005, 16:313-318. This paper explains how multiple risk factors can be integrated to improve the prediction of fracture risk.
39. Kanis JA, Oden A, Johnell O, et al.: The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 2001, 12:417-427.
40. Lewiecki EM: Review of guidelines for bone mineral density testing and treatment of osteoporosis. Curr Osteoporos Rep 2005, 3:75-83.
41. Kanis JA, Torgerson D, Cooper C: Comparison of the European and USA practice guidelines for osteoporosis. Trends Endocrinol Metab 2000, 11:28-32.
42. Physician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2003.
43. Berg AO: Screening for osteoporosis in postmenopausal women: recommendations and rationale. Am J Nurs 2003, 103:73-80.
44. Kanis JA, Johnell O, Oden A, et al.: Intervention thresholds for osteoporosis. Bone 2002, 31:26-31.
45. Kanis JA, Borgstrom F, Zethraeus N, et al.: Intervention thresholds for osteoporosis in the UK. Bone 2005, 36:22-32.
46. Kanis JA, Johnell O, Oden A, et al.: Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 2005, 16:6-14.
47. Ettinger B, Hillier TA, Pressman A, et al.: Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women. J Womens Health (Larchmt) 2005, 14:159-171. This paper shows the probable impact on clinical decision-making of implementing the proposed WHO algorithm.